Literature DB >> 1659182

Comparative features of carcinoma in situ and atypical ductal hyperplasia of the breast on fine-needle aspiration biopsy specimens.

C S Abendroth1, H H Wang, B S Ducatman.   

Abstract

With the use of fine-needle aspiration biopsy to evaluate non-palpable breast lesions, an increasing number of cases of ductal carcinoma in situ (DCIS) are encountered. The authors previously demonstrated that it is not possible to distinguish definitively between DCIS and invasive ductal carcinoma on fine-needle aspiration biopsy. To determine whether DCIS could be separated from atypical ductal hyperplasia (ADH), the authors identified all cases of exclusive DCIS or ADH with fine-needle aspiration biopsy before surgery. Sixteen cases of ADH and 19 cases of DCIS were identified. Of these, 12 in each category were sufficiently cellular to allow evaluation of architectural and cytologic features. Cases of ADH were more likely to be diagnosed as negative or atypical (11 of 12); in contrast, DCIS was more likely to be designated as suspicious or positive (9 of 12). Architectural and cytologic features characteristic of ADH included cells arranged in flat cohesive sheets, distinct cell borders, and myoepithelial cells. Those features characteristic of DCIS were single cells representing more than 10% of atypical cells, cellular dyshesion, and inflammatory background, coarsely granular chromatin, and nuclear pleomorphism. Many other features were not useful in separating ADH from DCIS. Based on this small series, it appears that the distinction between some cases of DCIS and ADH may be possible on fine-needle aspiration biopsy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1659182     DOI: 10.1093/ajcp/96.5.654

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy.

Authors:  M M Moore; C W Hargett; J B Hanks; L L Fajardo; J A Harvey; H F Frierson; C L Slingluff
Journal:  Ann Surg       Date:  1997-06       Impact factor: 12.969

2.  Determining factors which predict response to primary medical therapy in breast cancer using a single fine needle aspirate with immunocytochemical staining and flow cytometry.

Authors:  I N Fernando; T J Powles; M Dowsett; S Ashley; L McRobert; J Titley; M G Ormerod; N Sacks; M C Nicolson; A Nash
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  Stereotactic fine-needle aspiration biopsy for the evaluation of nonpalpable breast lesions: report of an experience based on 2,988 cases.

Authors:  J S Mitnick; M F Vazquez; P I Pressman; M N Harris; D F Roses
Journal:  Ann Surg Oncol       Date:  1996-03       Impact factor: 5.344

Review 4.  Evaluation and management of high risk and premalignant lesions of the breast.

Authors:  D L Page; R A Jensen
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

Review 5.  Anatomic indicators (histologic and cytologic) of increased breast cancer risk.

Authors:  D L Page; W D Dupont
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

6.  Time for evidence-based cytology.

Authors:  Pranab Dey
Journal:  Cytojournal       Date:  2007-01-08       Impact factor: 2.091

Review 7.  Grey zone lesions of breast: Potential areas of error in cytology.

Authors:  Suvradeep Mitra; Pranab Dey
Journal:  J Cytol       Date:  2015 Jul-Sep       Impact factor: 1.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.